|
Volumn 13, Issue 10, 2005, Pages 812-818
|
Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: A retrospective analysis of three clinical trials
|
Author keywords
Adherence to protocol therapy; Emesis; Survival
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
GEMCITABINE;
PACLITAXEL;
ABDOMINAL CRAMP;
ALLERGY;
ALOPECIA;
ANOREXIA;
ARTHRALGIA;
ARTICLE;
BREATHING DISORDER;
CANCER;
CANCER CHEMOTHERAPY;
CANCER PAIN;
CANCER PATIENT;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONSTIPATION;
COUGHING;
DATA ANALYSIS;
DIARRHEA;
DISEASE SEVERITY;
ECONOMIC ASPECT;
FATIGUE;
FEBRILE NEUTROPENIA;
FEVER;
HEARING IMPAIRMENT;
HEART ARRHYTHMIA;
HEART DISEASE;
HUMAN;
HYPOTENSION;
INCIDENCE;
INFECTION;
LENGTH OF STAY;
LETHARGY;
LUNG DISEASE;
MOTOR DYSFUNCTION;
MUCOSA INFLAMMATION;
MULTIVARIATE ANALYSIS;
MYALGIA;
NAUSEA;
PAIN;
POPULATION;
PRIORITY JOURNAL;
REGRESSION ANALYSIS;
RETROSPECTIVE STUDY;
SENSORY DYSFUNCTION;
SKIN DEFECT;
STATISTICAL SIGNIFICANCE;
STOMATITIS;
TOXICITY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CISPLATIN;
CLINICAL TRIALS, PHASE III;
EUROPE;
HUMANS;
NEOPLASMS;
PATIENT COMPLIANCE;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VOMITING;
|
EID: 26244461049
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s00520-005-0803-x Document Type: Article |
Times cited : (32)
|
References (8)
|